Back to Atlas
APotentially durableStandard research/education caution
CMP-0082
Approved in limited indications
Methyltestosterone
Ergogenic / AAS
Oral androgen replacement/anabolic-androgenic effects
Reading this compound Reference only
Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.
Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.
Mechanism & Use
- Compound type
- 17α-alkylated androgen
- Primary mechanism
- Androgen receptor agonist; A:A ratio ~1:1
- Primary market use
- Androgen replacement history
Pharmacology
- Molecular weight (Da)
- 302.45
- Oral bioavailability
- Oral; clinically active 17α-alkylated steroid
- Half-life
- ~2.5-3.5 h
- Route tags
- Oral
- Evidence level
- Approved/historical
- Clinical status
- Approved in limited indications
- Value-for-money score
- 4 / 10
Reported protocol signal
No popular protocol verified yet; keep as reference compound until protocol signal is added.
For orientation only. See disclaimer — always consult a licensed clinician before use.
Notes
Kuhn table groups methyltestosterone with testosterone at A:A ratio ~1.